Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ: TWST )

41.20 -0.11 (-0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers 
Via Benzinga
Twist Bioscience Q3 Sales Jump 60%, Raises FY22 Revenue Outlook Surpassing Consensus
Via Benzinga
Recap: Twist Bioscience Q3 Earnings
  Twist Bioscience (NASDAQ:TWST) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Earnings Preview
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Twist... 
Via Benzinga
Twist Bioscience to Present at Flash Memory Summit
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays
Via Benzinga
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
5 Top Stocks Cathie Wood Bought This Week
Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks. 
Via InvestorPlace
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
From Twist Bioscience Corporation
Via Business Wire
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
From DNAnexus, Inc.
Via Business Wire
7 Best Biotech Stocks to Buy in July 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. 
Via InvestorPlace
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows. 
Via Benzinga
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Via Benzinga
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Second Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.